Literature DB >> 16567868

Serosurvey of rubella in five blocks of Tamil Nadu.

Nalini Ramamurty1, S Murugan, D Raja, Varalaksmi Elango, D Dhanagaran.   

Abstract

BACKGROUND &
OBJECTIVE: Rubella, normally a mild, self-limiting disease characterized by rash, fever and lymphadenopathy, is a vaccine preventable disease. It carries little morbidity and apparently only minor complications in children. Infection during early pregnancy may lead to congenital rubella infection. Presence of rubella specific IgG in an unvaccinated population is a long term marker of previous rubella infection, which helps to assess the immune status of that population. Though many seroprevalence studies on rebella have been reported earlier from India, no study has been conducted in recent years. We undertook this study in 2003 in five blocks identified by the Integrated Child Development Scheme (ICDS), in the five districts of Tamil Nadu to assess the immune status to rubella in two age groups (1-5 yr boys and girls and 10-16 yr adolescent girls) before vaccination and draw strategies for future vaccination programme.
METHODS: A total of 300 blood samples were collected by vein puncture from girls and boys of 1-5 yr age and adolescent girls of 10-16 yr age. Samples were tested for the presence of rubella specific IgG antibody by ELISA.
RESULTS: Of the 300 samples tested, 145 (48.3%) were negative for rubella IgG antibodies. The seronegativity was 82.2 per cent in 1-5 yr and 13.5 per cent in the 10-16 yr age groups, the difference was statistically significant (P<0.001). INTERPRETATION &amp;
CONCLUSION: Large percentage of children, 82.2 per cent in the 1-5 yr age group and 13.5 per cent in 10-16 yr population were susceptible to rubella infection highlighting the fact that there was a risk of congenital rubella syndrome. There is a need to implement routine measles, mumps, rubella (MMR) immunization programme for under five children and mass scale one time immunization with monovalent rubella vaccine for adolescent girls.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16567868

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  9 in total

1.  Update on available vaccines in India: report of the APPA VU 2010: I.

Authors:  Sunil Karande
Journal:  Indian J Pediatr       Date:  2011-03-05       Impact factor: 1.967

2.  Sero-survey of rubella IgM antibodies among children in Jos, Nigeria.

Authors:  Surajudeen A Junaid; King J Akpan; Atanda O Olabode
Journal:  Virol J       Date:  2011-05-19       Impact factor: 4.099

3.  Rubella outbreak in a Rural Kenyan District, 2014: documenting the need for routine rubella immunization in Kenya.

Authors:  Ian Njeru; Dickens Onyango; Yusuf Ajack; Elizabeth Kiptoo
Journal:  BMC Infect Dis       Date:  2015-06-27       Impact factor: 3.090

4.  Prevalence of rubella-specific IgG antibodies in unimmunized young female population.

Authors:  Jayakrishnan Thayyil; Vidya Kuniyil; Anitha P Moorkoth; Bhaskar Rao; Paramasivam Selvam
Journal:  J Family Med Prim Care       Date:  2016 Jul-Sep

5.  Seroprevalance of Rubella in an Urban Infertility Clinic - Observations and Challenges Ahead.

Authors:  Aby Kottal Koshy; Jijo George Varghese; Jeethu Issac
Journal:  J Hum Reprod Sci       Date:  2018 Oct-Dec

6.  Rubella seroprevalence among primary and pre- primary school pupils at Moi's Bridge location, Uasin Gishu District, Kenya.

Authors:  Janeth J Kombich; Paul C Muchai; Peter Tukei; Peter K Borus
Journal:  BMC Public Health       Date:  2009-07-29       Impact factor: 3.295

7.  An outbreak of rubella in a hilly district of Kangra-Chamba, Himachal Pradesh, India, 2006.

Authors:  Surender Nikhil Gupta; Naveen Nikhil Gupta
Journal:  Indian J Pediatr       Date:  2009-04-16       Impact factor: 5.319

8.  Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial.

Authors:  Sanjay Lalwani; Sukanta Chatterjee; Sundaram Balasubramanian; Ashish Bavdekar; Shailesh Mehta; Sanjoy Datta; Michael Povey; Ouzama Henry
Journal:  BMJ Open       Date:  2015-09-11       Impact factor: 2.692

9.  Epidemiology of primary rubella infection in the Central African Republic: data from measles surveillance, 2007-2014.

Authors:  Alain Farra; Marilou Pagonendji; Alexandre Manikariza; Dieubéni Rawago; Rock Ouambita-Mabo; Gilbert Guifara; Ionela Gouandjika-Vasilache
Journal:  BMC Infect Dis       Date:  2016-09-23       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.